EGFR and head and neck squamous cell carcinoma: Epidermal growth factor receptor‐targeted antibody nimotuzumab combined with chemoradiotherapy improves survival in patients with locally advanced head and neck squamous cell carcinoma: a propensity score matching real‐world study